As of 2025-05-16, the Fair Value of Humacyte Inc (HUMA) is -4.93 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.87 USD, the upside of Humacyte Inc is -363.50%.
With the market price of 1.87 USD and our fair value calculation, Humacyte Inc (HUMA) is not a good investment. Investing in HUMA stocks now will result in a potential loss of 363.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -66.52 | -26.48 | -11.97 | -110.78 | -53.94 | |
| YoY growth | 22.13% | 60.19% | 54.80% | -825.45% | -172.08% | |
| Market Cap (mil) | 221.33 |
| P/E | |
| Forward P/E |
| EPS | -0.99 |
| Avg earnings growth rate | -172.08% |
| TTM earnings | -152.87 |